AIM ImmunoTech (AIM) Return on Capital Employed [ROCE] (2011 - 2026)
AIM ImmunoTech (AIM) posted Return on Capital Employed [ROCE] of -194.99% for Q2 2026, up 794.03 percentage points from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, AIM ImmunoTech's Return on Capital Employed [ROCE] came in at -1201.24%, down 757.87 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has declined for four consecutive years, with a five-year change of -1164.78 percentage points (FY2020 to FY2025).
- In prior years, AIM ImmunoTech's Return on Capital Employed [ROCE] was -443.37% in FY2024 (-293.40 pp), -149.96% in FY2023 (-108.22 pp), -41.74% in FY2022 (-10.59 pp) and -31.15% in FY2021 (+5.30 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2023.
- Across the past five years, year-over-year drop in Return on Capital Employed [ROCE] ran from 2.53 percentage points in Q3 2021 to 1282.06 percentage points in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.76% |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | -194.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -194.99% |
| Mar 31, 2026 | -989.02% |
| Sep 30, 2025 | -1,895.51% |
| Dec 31, 2024 | -1,265.00% |
| Sep 30, 2024 | -613.45% |
| Jun 30, 2024 | -444.29% |
| Mar 31, 2024 | -421.75% |
| Dec 31, 2023 | -213.22% |
| Sep 30, 2023 | -90.19% |
| Jun 30, 2023 | -66.86% |
| Mar 31, 2023 | -56.73% |
| Dec 31, 2022 | -47.41% |
| Sep 30, 2022 | -47.74% |
| Jun 30, 2022 | -37.58% |
| Mar 31, 2022 | -33.07% |
| Dec 31, 2021 | -31.54% |
| Sep 30, 2021 | -25.79% |
| Jun 30, 2021 | -22.97% |
| Mar 31, 2021 | -22.80% |
| Dec 31, 2020 | -23.98% |
API Access
AIM ImmunoTech Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();